Literature DB >> 2546489

Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

S C Harris1, J E Wallace, G Foulds, M G Rinaldi.   

Abstract

A megabore column gas-liquid chromatographic method which uses nitrogen-phosphorus detection was developed for the analysis of fluconazole in plasma, serum, cerebrospinal fluid, or urine. The assay was linear from 0.2 to 200 micrograms/ml and had an average coefficient of variation of 7%. The suitability of the assay for pharmacokinetic studies was demonstrated.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2546489      PMCID： PMC172520          DOI： 10.1128/AAC.33.5.714

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  27 in total

1.  Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system.

Authors:  C A Arndt; T J Walsh; C L McCully; F M Balis; P A Pizzo; D G Poplack
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

2.  Bactericidal effect of combinations of antimicrobial drugs and antineoplastic antibiotics against Staphylococcus aureus.

Authors:  J Y Jacobs; J Michel; T Sacks
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

3.  Obfuscation of the activity of antifungal antimicrobics by culture media.

Authors:  P D Hoeprich; P D Finn
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

4.  In vitro synergy and antagonism of antifungal agents against yeast-like fungi.

Authors:  B Dupont; E Drouhet
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

5.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

6.  Incidence and susceptibility of yeasts isolated from cancer patients in Kuwait.

Authors:  M A Ghannoum; M S Motawy; A L Mubarak; H A Al-Awadhi
Journal:  Mykosen       Date:  1985-12

7.  Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  1980-11       Impact factor: 5.790

8.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

9.  Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.

Authors:  J Brajtburg; D Kobayashi; G Medoff; G S Kobayashi
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

10.  Combined activity of minocycline and amphotericin B in vitro against medically important yeasts.

Authors:  M A Lew; K M Beckett; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191
View more
  22 in total

1.  Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column.

Authors:  J E Wallace; S C Harris; J Gallegos; G Foulds; T J Chen; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

2.  Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay.

Authors:  David Zhuang; Melinda Smedema; Ann Lemonte; Benita K Book; Mark D Pescovitz; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

3.  Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography.

Authors:  J H Rex; L H Hanson; M A Amantea; D A Stevens; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam.

Authors:  J Ahonen; K T Olkkola; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

5.  In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.

Authors:  G S Kobayashi; S J Travis; M G Rinaldi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis.

Authors:  R Allendoerfer; R R Yates; A J Marquis; D Loebenberg; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 7.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.

Authors:  W Manosuthi; P Chetchotisakd; T L Nolen; D Wallace; S Sungkanuparph; T Anekthananon; K Supparatpinyo; P G Pappas; R A Larsen; S G Filler; D Andes
Journal:  HIV Med       Date:  2009-12-08       Impact factor: 3.180

9.  Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination.

Authors:  M M Albert; J R Graybill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 10.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.